Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- KINGS COLLEGE LONDON
- Nature Careers
- University of North Carolina at Chapel Hill
- Rutgers University
- University of Minnesota
- ;
- Stanford University
- The Ohio State University
- The University of Arizona
- University of Oxford
- University of Texas at Tyler
- University of Twente
- King's College London
- Pennsylvania State University
- University of Minnesota Twin Cities
- University of Texas at Dallas
- Duke University
- Stony Brook University
- Technical University of Denmark
- Texas A&m Engineering
- UNIVERSITY OF VIENNA
- University of Southern California
- University of Southern Denmark
- University of Washington
- ; University of Oxford
- Baylor College of Medicine
- Canadian Association for Neuroscience
- Chalmers University of Technology
- City University London
- Durham University
- Emory University
- Fred Hutchinson Cancer Center
- Harvard University
- Heriot Watt University
- Institut Pasteur
- Kennesaw State University
- Linköping University
- Loyola University
- Manchester Metropolitan University
- Max Planck Institute of Biochemistry, Martinsried
- Medical College of Wisconsin
- Ryerson University
- SUNY University at Buffalo
- SciLifeLab
- South Dakota Mines
- The University of Iowa
- University of California Irvine
- University of Cambridge
- University of Connecticut
- University of London
- University of North Texas at Dallas
- VIB
- Villanova University
- Washington University in St. Louis
- Yale University
- 45 more »
- « less
-
Field
-
Center Department: Medicine | School Biomedical Sciences Cancer Biology and Genetics A postdoctoral scholar is immediately available in the laboratory of Dr. Nam Chu, within the Department of Cancer
-
Health Program Program Type: Postdoctoral Location: Durham, North Carolina 27708, United States of America [map ] Subject Areas: Biology Mechanical Engineering Public Health Biomedical Engineering
-
signaling and contributions from the tumor microenvironment, to improve therapy and survival outcomes in lung cancer patients. What You’ll Do: Conduct and design independent research projects Perform CRISPR
-
principles driving tumor progression, including both cancer cell-intrinsic signaling and contributions from the tumor microenvironment, to improve therapy and survival outcomes in lung cancer patients. What
-
resistance mechanisms underlying disease development, genetic and epigenetic biomarkers for lung cancer precision medicine, and signal transduction changes during disease progression. A strong background in
-
biology, genetics, physiology or biomedicine and have a strong track record of, and potential for, success. The applicant should have a keen research interest in cell signaling, calcium dynamics
-
vaccines, Fred Hutch has earned a reputation as one of the world's leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical
-
are to independently investigate the regulation of receptor tyrosine kinase signaling and its influence on tumor response to treatment, to elucidate the mechanism by which PI3K mutations alter sensitivity to both DNA
-
novel proteins/antibodies and explore their biomedical applications. Our goal is to utilize these engineered proteins to precisely regulate intracellular signaling pathways, eventually translating
-
academic Chair, where we interface robotic technologies with the neuromuscular system to improve movement. We apply artificial intelligence, computational modelling and biological signal processing, in a